secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0000950170-24-086026
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo received Nasdaq delisting notice for bid price below $1 per share
--------------------------------------------------------------------------

- Nasdaq notice on July 18, 2024: closing bid price below $1 for 30 consecutive business days.
- 180-day compliance period granted until January 14, 2025 to regain bid price rule.
- To regain compliance, closing bid must be at least $1 for ten consecutive business days.
- Company may consider reverse stock split subject to stockholder approval if not cured.
- Trading of ONVO common stock continues on Nasdaq Capital Market without immediate effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024086026/0000950170-24-086026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024086026/onvo-20240718.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-086026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer